Direct medical costs for partial refractory epilepsy in Mexico

Archives of Medical Research

Volumn 37, Issue 3, 2006, Pages 376-383

  García Contreras, Fernando ^a   Constantino Casas, Patricia ^a   Castro Ríos, Angélica ^a   Nevárez Sida, Armando ^a   Del Carmen Estrada Correa, Gloria ^b   Carlos Rivera, Fernando ^a   Guzmán Caniupan, Jorge ^a   Del Pilar Torres Arreola, Laura ^a   Contreras Hernández, Iris ^a   Mould Quevedo, Joaquin ^a   Garduño Espinosa, Juan ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Hospital Especialidades C M La Raza   (Mexico)

Author keywords

Direct medical cost; Economic evaluation; Epilepsy; Healthcare costs; Partial refractory epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADULT; CONTROLLED STUDY; DRUG COST; ECONOMIC EVALUATION; EPILEPSY; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; MALE; MEXICO; REVIEW; SEIZURE;

EID: 33644532197     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2005.07.005     Document Type: Article

References (34)

1. J. Engel, and T.A. Pedley What is epilepsy? J. Engel Jr. T.A. Pedley Epilepsy: A Comprehensive Textbook 1999 Lippincott-Raven Philadelphia 1 8
2. Organización Mundial de la Salud, Fact Sheet No. 165, February 2001.
3. W.A. Hauser, R. Ortega, and M. Zaarelli The prevalence of epilepsy in a rural Mexican village Epilepsia 31 1990 604
4. Secretaría de Salud, México. Programa de Atención a la Epilepsia. http://www.salud.gob.mx/unidades/conadic/epi_frecmex.htm (accessed on January 2005).
5. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised clinical and electroencephalographic classification of epileptic seizures Epilepsia 22 1981 489 501
6. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised classification of epilepsies and epileptic syndromes Epilepsia 30 1989 389 399
7. S.R. Benbadis Epileptic seizures and syndromes Neurol Clin 19 2001 251 570
8. B. Chang, and D. Lowenstein Mechanisms of disease: epilepsy N Engl J Med 349 2003 1257 1266
9. N. Callaghan, A. Garrett, and T. Goggin Withdrawal of anticonvulsant drugs in patients free of seizures for two years: a prospective study N Engl J Med 318 1988 942 946
10. G.L. Morris Gabapentin Epilepsia 40 Suppl 5 1999 S63 S70
11. A.J. Rowan Valproate J. Engel Jr. T.A. Pedley Epilepsy: A Comprehensive Textbook Vol. 2 1998 Lippincott-Raven Philadelphia 1599 1607
12. J.C. Sackellares, and S. Berent Psychological Disturbances in Epilepsy 1996 Butterworth-Heinemann Boston
13. S.D. Shorvon, K. van Rijckevorsel, and P. Verdru Pooled efficacy and safety data of levetiracetam (LEV) used as adjunctive therapy in patients with partial onset seizures Epilepsia 40 Suppl 1999 76
14. T.A. Glauser Topiramate Epilepsia 40 Suppl 5 1999 S71 S80
15. th ed. 1995 Raven Press New York
16. F. Matsuo Lamotrigine Epilepsia 40 Suppl 5 1999 S30 S36
17. B. Bourgeois General concepts of medical intractability H.O. Luders Epilepsy Surgery 1991 Raven Press New York 77 81
18. S. Sato, B.G. White, J.K. Penry, F.E. Dreifuss, J.C. Sackellares, and H.J. Kupferberg Valproic acid versus ethosuximide in the treatment of absence seizures Neurology 32 1982 157 163
19. G.D. Cascino Intractable partial epilepsy: evaluation and treatment Mayo Clin Proc 65 1990 1578 1586
20. World Health Organization, Fact Sheet No. 165. February 2001.
21. J. Engel Jr. Surgery for seizures N Engl J Med 334 1996 647 652
22. R.S. Fisher, G.L. Krauss, E. Ramsay, K. Laxer, and J. Gates Assessment of vagus nerve stimulation for epilepsy: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology 49 1997 293 297
23. 40 Principales motivos de demanda en el sistema de consulta externa en Medicina Familiar. Total Nacional 2002 (Instituto Mexicano del Seguro Social). http://www.imss.gob.mx/dpm/dties//Celula.aspx?ID=SC06_00_00_01_03&OPC= opc07&SRV=SRV02&Men=1 (accessed on January 2005).
24. Economic aspects of epilepsy Epilepsia 44 2003 54 56
25. C.E. Begley, and E. Beghi The economic cost of epilepsy: a review of the literature Epilepsia 43 Suppl 4 2002 3 9
26. Informe de la Dirección General XCIV Asamblea General Ordinaria IMSS August 2004 10
27. P. Jallon Epilepsy in developing countries Epilepsia 38 1997 1143 1151
28. J.F. Annegers, E. Beghi, and C.E. Begley Cost of epilepsy: contrast of methodologies in United States and European studies Epilepsia 40 Suppl 8 1999 14 18
29. M. Platt, and M.R. Sperling A comparison of surgical and medical costs for refractory epilepsy Epilepsia 43 2002 25 31
30. A. Jacob, D. Buck, G. Baker, P. McNamee, S. Graham-Jones, and D. Chadwick Uptake and costs of care for epilepsy: findings from a U.K. regional study Epilepsia 39 1998 776 786
31. M. De Zelicourt, L. Buteau, F. Fagnani, and P. Jallon The contributing factors to medical cost of epilepsy based on a French prospective cohort study of patients with newly diagnosed epileptic seizure Seizure 9 2000 88 95
32. C.E. Begley, A. Famulari, J.F. Annegers, D.R. Lairson, T.F. Reynolds, S. Coan, S. Dubinsky, M.E. Newmark, C. Leibson, E.L. So, and W.A. Rocca The cost of epilepsy in the United States: an estimate from population-based and survey data Epilepsia 41 2000 342 351
33. J.C. Sánchez-Alvarez, A. Altuzarra-Corral, J.M. Mercadé-Cerdá, J.L. Casado-Chocán, V. Moreno-Alegre, M. Rufo-Campos, R. Camino-León, J.M. Galán-Barranco, E. Pita-Calandoe, J. Ramos-Lizana, and P.J. Serrano-Castro Guía Terpéutica en epilepsia de la Sociedad Andaluza de Epilepsia 2005: IV. Principios generales de politerapia antiepiléptica y estrategias terapéuticas en epilepsia refractaria Rev Neurol 40 2005 743 750
34. J.C. Sánchez-Alvarez, P.J. Serrano-Castro, and F. Cañadillas-Hidalgo Epilepsia refractaria del adulto Rev Neurol 35 2002 931 953